Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1

Despite advances in colon cancer treatments, resistance and recurrence remain a significant challenge in treating patients. Novel therapeutic strategies are in urgent need to overcome resistance and improve patient outcomes. MicroRNA based therapeutics have potential to help combat resistance. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fesler, Andrew, Liu, Hua, Ju, Jingfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788646/
https://www.ncbi.nlm.nih.gov/pubmed/29416778
http://dx.doi.org/10.18632/oncotarget.23414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788646/
https://www.ncbi.nlm.nih.gov/pubmed/29416778
http://dx.doi.org/10.18632/oncotarget.23414

Ejemplares similares